Page last updated: 2024-10-29

iohexol and Postthrombotic Syndrome

iohexol has been researched along with Postthrombotic Syndrome in 1 studies

Iohexol: An effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality.
iohexol : A benzenedicarboxamide compound having N-(2,3-dihydroxypropyl)carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and an N-(2,3-dihydroxypropyl)acetamido group at the 5-position.

Postthrombotic Syndrome: A condition caused by one or more episodes of DEEP VEIN THROMBOSIS, usually the blood clots are lodged in the legs. Clinical features include EDEMA; PAIN; aching; heaviness; and MUSCLE CRAMP in the leg. When severe leg swelling leads to skin breakdown, it is called venous STASIS ULCER.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Helyar, VG1
Gupta, Y1
Blakeway, L1
Charles-Edwards, G1
Katsanos, K1
Karunanithy, N1

Other Studies

1 other study available for iohexol and Postthrombotic Syndrome

ArticleYear
Depiction of lower limb venous anatomy in patients undergoing interventional deep venous reconstruction-the role of balanced steady state free precession MRI.
    The British journal of radiology, 2018, Volume: 91, Issue:1082

    Topics: Adolescent; Adult; Aged; Angiography, Digital Subtraction; Contrast Media; Female; Humans; Iohexol;

2018